Carbamazepine description, usages, side effects, indications, overdosage, supplying and lots more!

Menu
Search

Carbamazepine

REMEDYREPACK INC.


FULL PRESCRIBING INFORMATION: CONTENTS*




FULL PRESCRIBING INFORMATION

BOXED WARNING



WARNINGSLABORATORY TESTS





CARBAMAZEPINE DESCRIPTION


Carbamazepine






CLINICAL PHARMACOLOGY



Mechanism of Action



PHARMACOKINETICS

Drug Interactions



INDICATIONS & USAGE

Epilepsy



General

Trigeminal Neuralgia




CARBAMAZEPINE CONTRAINDICATIONS




WARNINGS

Serious Dermatologic Reactions


SJS/TEN and HLA-B*1502 Allele



WARNINGSLaboratory Tests





Aplastic Anemia and Agranulocytosis


Suicidal Behavior and Ideation










General





Usage in Pregnancy










PRECAUTIONS

General

INDICATIONS AND USAGE


ADVERSE REACTIONSLaboratory Tests
ADVERSE REACTIONS, OtherInformation for Patients



INFORMATION FOR PATIENTS






Usage in Pregnancy

LABORATORY TESTS

WARNINGS

GeneralADVERSE REACTIONS


CLINICAL PHARMACOLOGY




Drug Interactions


Agents That May Affect Carbamazepine Plasma Levels









Effect of Carbamazepine on Plasma Levels of Concomitant Agents




CONTRAINDICATIONS




CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY




PREGNANCY

WARNINGS

LABOR & DELIVERY



NURSING MOTHERS




PEDIATRIC USE

INDICATIONS AND USAGE



GERIATRIC USE



CARBAMAZEPINE ADVERSE REACTIONS


BOXED WARNING



BOXED WARNING













Laboratory Tests
GeneralInformation for Patients



DRUG ABUSE AND DEPENDENCE




OVERDOSAGE




Signs and Symptoms









Treatment















DOSAGE AND ADMINISTRATION (SEE TABLE BELOW)
Laboratory Tests

INDICATIONS AND USAGE



Drug InteractionsPregnancy Category D
INDICATIONS AND USAGE


Dosage Information




HOW SUPPLIED

























STORAGE AND HANDLING



PACKAGE LABEL.PRINCIPAL DISPLAY PANEL SECTION














Carbamazepine

Carbamazepine

Carbamazepine

Carbamazepine TABLET, CHEWABLE

Product Information

Product Type Human prescription drug label Item Code (Source) NDC:49349-694(NDC:13668-271)
Route of Administration ORAL DEA Schedule

Active Ingredient/Active Moiety

Ingredient Name Basis of Strength Strength
CARBAMAZEPINE Carbamazepine 100 mg

Inactive Ingredients

Ingredient Name Strength
SILICON DIOXIDE
SUCROSE
STARCH, CORN
FD&C RED NO. 40
HYPROMELLOSES
MAGNESIUM STEARATE
SODIUM STARCH GLYCOLATE TYPE A POTATO

Product Characteristics

Color Size Imprint Code Shape
pink 10 mm 271 ROUND

Packaging

# Item Code Package Description Marketing Start Date Marketing End Date
1 NDC:49349-694-02 30 in 1 BLISTER PACK

Marketing Information

Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA075712 2011-07-13


PLEASE, BE CAREFUL!
Be sure to consult your doctor before taking any medication!
Copyright © 2014. drugs-library.com. All rights reserved. Information on drugs-library.com is provided for educational purposes only and is not to be used for medical advice, diagnosis or treatment.
Support info@drugs-library.com.